Vancomycin resistant enterococci - A threat to the nephrologist on the horizon? Glycopeptide-resistant enterococci and ICDC-recommendations for a limited use of glycopeptides

Nephrology Dialysis Transplantation

Volumn 11, Issue 12, 1996, Pages 2402-2406

  Lameire, Norbert ^a   Vogelaers, Dirk ^a   Verschraegen, Gerda ^a   Veys, Nic ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

POLYPEPTIDE ANTIBIOTIC AGENT; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; BACTERIAL INFECTION; ENTEROCOCCUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PRIORITY JOURNAL; REVIEW;

EID: 0030464143     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.ndt.a027202     Document Type: Review

References (32)

1. Emori TG, Gaynes RP. An overview of nosocomial infections, including the role of the microbiology laboratory. Clin Microbiol Rev 1993; 6: 428-442
2. Schaberg DR, Culver DH, Gaynes RP. Major trends in the microbial etiology of nosocomial infections. Am J Med 1991; 91 (Suppl 3B): 72S-75S
3. Banerjee SN, Emori TG, Culver DH, et al. Secular trends in nosocomial primary bloodstream infections in the United States 1980 1989. Am J Med 1991; 91 (suppl 3B): 86S-89S
4. Gin AS, Zhanel GG. Vancomycin-resistant enterococci. Ann Pharmacotherapy 1996; 30: 615-624
5. Leclercq R, Courvalin P. Emerging problems with enterococcal infections. Curr Opin Infect Dis 1996; 9: 115-119
6. Leclercq R, Derlot E, Duval J, Courvalin P. Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. N Engl J Med 1988; 319: 157-161
7. Noble WC, Virani Z, Cree RGA. Co-transfer of vancomycin and other resistance genes from Enterococcus faecalis NCTC 12201 to Staphylococcus aureus. FEMS Microbiol Lett 1992; 93: 195-198
8. Nosocomial enterococci resistant to vancomycin - United States 1989 1993. MMWR Morb Mortal Wkly Rep 1993; 42: 597-599
9. Uttley AHC, Collins CH, Naidoo J, George RC. Vancomycin-resistant enterococci. Lancet 1988; 1: 57-58
10. Uttley AHC, George RC, Naidoo J, Woodford N, Johnson AP, Collins CH et al. High-level vancomycin-resistant enterococci causing hospital infections. Epidemiol Infect 1989; 103: 173-181
11. Vercauteren E, Leclercq R, Goossens H. Belgian surveillance study of enterococcal susceptibility patterns. In: Program and Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington DC: American Society for Microbiology; 1994 (Abstract 10).
12. Schmit JL, Leclercq R, Scheimberg A, Landauer D: Epidemiological and clinical approach of the enterococci: results of a survey. Med Mal Infect 1994; 24: 141-148
13. Bates J, Jordens JZ, Griffiths DT. Farm animals as a putative reservoir for vancomycin-resistant enterococcal infection in man. J Antimicrob Chemother 1994; 34: 507-516
14. a; 1: 265-272
15. b; 125: 165-172
16. Aarestrup FM. Occurrence of glycopeptide resistance among Enterococcus faecium isolates from conventional and ecological poultry farms. Microb Drug Res 1995; 1: 255-257
17. Gordts B, Van Landuyt H, Ieven M, Vandamme P, Goossens H. Vancomycin-resistant enterococci colonizing the intestinal tracts of hospitalized patients. J Clin Microb 1995; 33, 11: 2842-2846
18. Van der Auwera P, Pensart N, Korten V, Murray BE, Leclercq R. Influence of oral glycopeptides on the fecal flora of human volunteers: selection of highly glycopeptide-resistant enterococci. J Infect Dis 1996; 173: 1129-1136
19. Vercauteren E, Leclercq R, Goossens H. Belgian. Surveillance study of enterococcal susceptibility patterns. In: Program and Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington DC. American Society for Microbiology 1994; (abstract E10)
20. Ena J, Dick RW, Jones RN, Wenzel RP. The epidemiology of intravenous vancomycin usage in a university hospital. JAMA 1993; 269: 598-602
21. Korten V, Murray BE. The nosocomial transmission of enterococci. Curr Opin Infect Dis 1993; 6: 498-505
22. Linden PK, Pasculle AW, Manez R, et al. Differences in outcomes for patients with bacteremia due to vancomycin-resistant Enterococcus faecium or vancomycin-susceptible E. faecium. Clin Infect Dis 1996; 22: 663-670
23. Shay DK, Maloney SA, Montecalvo M, et al. Epidemiology and mortality risk of vancomycin-resistant enterococcal blood-stream infections. J Infect Dis 1995; 172: 993-1000
24. Federal Register - US Department of Health and Human Services - Centres for Disease Control and Prevention. Preventing the spread of vancomycin resistance. Report from the Hospital Infection Control Practices Advisory Committee 1994; 59: 25758-25763
25. Recommendations for preventing the spread of vancomycin resistance: recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC). Am J Infect Control 1995; 23: 87-94
26. Capdevila JA, Segarra A, Planes AM, et al. Successful treatment of haemodialysis catheter-related sepsis without catheter removal. Nephrol Dial Transplant 1993; 8: 231-234
27. Keane WF, Everett ED, Golper TA, et al. Peritoneal dialysis-related peritonitis treatment recommendations - 1993 update. Perit Dial Int 1993; 13: 14-28
28. Vas SI. Treatment of peritonitis. Perit Dial Int 1994; 14, Suppl 3, S49-S55
29. Small PM, Chambers HF. Vancomycin for Staphylococcus aureus endocarditis in intravenous drug users. Antimicrob Agents Chemother 1990; 34; 1227-1231
30. Korzeniowski O, Sande MA, and the National Collaborative Endocarditis Study Group. Combination antimicrobial therapy for Staphylococcus aureus endocarditis in patients addicted to parenteral drugs and in non-addicts: a prospective study. Ann Intern Med 1982; 97: 496-503
31. Chambers HF, Miller RT, Newman MD. Two-week combination therapy of right-sided Staphylococcus aureus endocarditis in intravenous drug abusers. Ann Int Med 1988; 109: 619-624
32. Edmiston CE. Vancomycin resistance: when failure becomes an opportunity for leadership. Ann Pharmacotherapy 1996; 30: 680-682